Has Sijan Basnet, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,869 in general payments to Sijan Basnet, MD across 152 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sijan Basnet, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sijan Basnet, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sijan Basnet, MD

Internal Medicine · West Reading, PANPI 1386097202

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,291 of the $5,869 with a category attached, or 73.1%. 15 manufacturers reported payments, led by Medtronic at 24.4% of the total. 2025 is the largest year on record at $3,852, 4.0 times the $975 reported in 2023. Among internal medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,869in general payments, 2019–2025

Across 152 payments — averaging $38.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$1K
Abbott$1K
Pfizer$829
E.r. Squibb & Sons, L.L.C.$553
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$424
Johnson & Johnson$361
plus $860 from 9 others

What the payments were for

Travel & lodging$86615%
Food & beverage$4,29173%
Education$71212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	19	$1,434
Abbott	16	$1,409
Pfizer	38	$829
E.r. Squibb & Sons, L.L.C.	24	$553
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	16	$424
Johnson & Johnson	10	$361
Scpharmaceuticals Inc.	9	$286
AstraZeneca	10	$196
Impulse Dynamics (USA) Inc.	4	$180
Novartis	1	$86
Mannkind Corporation	1	$28
Kiniksa Pharmaceuticals International, PLC	1	$27
Lantheus Medical Imaging, Inc.	1	$22
Edwards Lifesciences	1	$21
Inspire Medical Systems, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VenaSeal$816
ENSITE$613
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$277
CARDIOMEMS$132
FUROSCIX$110
LifeVest$101

How this compares

$5,869 in reported general payments places this provider in the 90th percentile of 5,705 internal medicine providers in Pennsylvania.

See all internal medicine providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$10,101

Medicare patients

Services billed

111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	43	$329
Atorvastatin Calcium	13	$120
Lisinopril	11	$92
Amlodipine Besylate	16	$62
Losartan Potassium	18	$46

Paid to pharmacies, not to this prescriber.